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CASE REPORT
Neonatal Purpura Fulminans, a rare genetic disorder due to protein C
deficiency: A case report
Sayyeda Ghazala Irfan Kazi,1 Emaduddin Siddiqui,2 Irfan Habib,3 Saadia Tabassum,4 Badar Afzal,5 Irum Qamar Khan6

Abstract
Neonatal Purpura Fulminans is a rare and fatal disorder
associated with perivascular haemorrhage and
disseminated intravascular coagulation. Early clinical
recognition, timely investigation and treatment is
utmost important. A 6 days old baby boy was brought
to emergency with blackish ulcers all over the body.
Initially these were over the feet and scalp but later
appeared on the abdomen. On examination, child was
vitally stable, mildly icteric and had multiple
erythematous large bullous blackish lesions on scalp,
lower abdomen, perineum, back and soles. Neonatal
reflexes and systemic examination was normal.
Laboratory investigations showed normal CBC, PT/APTT
and Protein S level while Protein C and Antithrombin III
levels were low.
Neonatal Purpura Fulminans is a life threatening
condition and family screening is also mandatory for early
recognition of disease in the siblings.
Keywords: Neonatal Purpura Fulminans, Protein C.

Introduction
Neonatal Purpura Fulminans (PF) is a clinical condition
due to dermal micro vascular thrombosis; PF is a rare
and often fatal disorder associated with perivascular
haemorrhage and disseminated intravascular
coagulation (DIC), initially present at neonatal age. Early
clinical recognition, timely investigation and treatment
is utmost important. PF, was first described in 1962 as a
suspected inherited lesion found in three siblings with
similar skin lesions.1 Homozygous type protein C or
proteins S deficiencies are rare genetic disorders with
fatal PF like thrombotic complications mostly
manifested during neonatal period. 2 The clinical
presentation of typical rash of PF is of well-demarcated
erythematous macules, which progress rapidly with
irregular central areas of blue-black haemorrhagic
necrotic areas.3 Patients with PF may also present with
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multi-organ failure or with severe large venous
thrombosis with high initial mortality and long-term
morbidity, hence early recognition and diagnosis of the
initiating cause of PF may avert these adverse
outcomes.4

Case Report
A 6 days old baby boy, resident of Multan, was brought
to the emergency department of our institute in
November 2013 with the complaints of blackish ulcers
all over the body started from second day of life. Initially
these patches were over the feet and scalp but later
they appeared on the abdomen as well (Figure-1). The
child was otherwise healthy and was taking feeds
normally. The antenatal and birth history were
insignificant. He was a product of consanguineous
marriage with one healthy male sibling alive. Family
history was significant with the occurrence of same skin
lesions in a baby girl developed on second day of life
and then death of that girl in the neonatal period. On
examination, child was vitally stable with heart rate of
140 beats/min, respiratory rate 38 breaths/min, and
temperature of 37°C. Child was mildly icteric and had
multiple erythematous and large bullous lesions of
black colour on scalp, lower abdomen, perineum, back
and soles of both feet (Figure-2,3). Neonatal reflexes
were normal and systemic examination was also
normal. Suspecting neonatal Purpura Fulminans,
laboratory investigations including complete blood
count (CBC), Prothrombin time (PT), Activated Partial
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Figure-1: Large necrotic lesion on right sole.
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other congenital thrombophilia.7
The occurrence of Protein C
deficiency is 1 in 40000-25 0000
individuals and is vitamin Kdependent coagulation protein,
synthesized in liver.
Neonatal Purpura Fulminans
usually presents with a rapid
onset of purpuric lesions within
first 24 hours of life. The clinical
presentation may vary depending
on the severity of congenital
protein C and S deficiencies. The
skin lesions initially appear dark
red and then become purpleblack and indurated. They may be
mistaken initially as bruising but
later become necrotic and
gangrenous which may results in
extremities loss.8 Ophthalmologic
complications including vitreous
haemorrhage
and
retinal
Figure-2: Large purpuric to blackish bullous lesion over lower abdomen extending up to the inguinal region.
detachment that may result in
partial or complete blindness are
Thromboplastin Time (APTT), Protein C, and Protein S
often associated with severe protein C deficiency.9
were sent which showed following results:
Purpura Fulminans is a haematological emergency so
Complete Blood Count (CBC): Hb 11.3 g/dl, HCT 36.3%,
early recognition and initiation of immediate treatment to
WBC 22.7/cu mm with neutrophils 46% and lymphocytes
prevent the complications is mandatory. Immediate
27.7%, and platelets 146/cu mm. Prothrombin Time (PT):
treatment is the transfusion of FFP to replace pro11.7 seconds. Activated Partial Thromboplastin Time
coagulants and anticoagulants that have been consumed.
(APTT): 40.1seconds. Protein C level: 10% (72-106 %).
The main concern of transfusing FFP is to replace Protein
Protein S level: 62.2% (60-110%). Antithrombin III: 59.7%
C and Protein S which are severely deficient.3 Protein C
(80-120%).
concentrate is recommended in severe heritable
deficiency of Protein C after confirming the diagnosis to
Paediatric haematology and neonatology was taken on
minimize
the use of FFP.
board and admission was advised for Fresh Frozen Plasma
(FFP) transfusion and further management but father
refused to hospitalize the patient and took the baby back
home. Later we contacted for follow up and got the
information that the patient had expired on 23rd day of
life as the elder sister.

Discussion and Conclusion
Neonatal Purpura Fulminans was assumed as an
inherited disorder due to the presence of similar skin
lesions in three siblings when it was first described in
1962.5 Relationship of PF and protein C deficiency was
first described in 1983, and was effectively treated
with protein C replacement therapy. 6 Inherited causes
of PF have been associated with homozygous
deficiency of protein C or S, other than complex
heterozygous and/or may be as co-inheritance with

Neonates and children with severe protein C deficiency
are at risk of recurrent PF and hence require long-term
treatment with antithrombotic drugs are recommended.
Replacement of protein C either alone, or in combination
with coumarins or low molecular weight heparin is main
stay of management.10
Neonatal Purpura Fulminans is a life threatening
condition although it is very rare but early diagnosis
and prompt management is crucial to prevent the
complications and improve morbidity as well as
mortality. Inherited causes require long term
treatment with replacement of anticoagulant therapy
and fresh frozen plasma. Family screening is also
mandatory for early recognition of disease in the
siblings.
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